V CompBrief BY VELARION

Former Chief Financial Officer · Ventyx Biosciences, Inc. (VTYX)

Martin Auster

FY2024 is the first fiscal year CompBrief holds for Martin Auster as a named executive officer of Ventyx Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$995,179

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A).

Martin Auster compensation by year

Ventyx Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Ventyx Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$317,179
Bonus$0
Stock awards$0
Option awards$245,000
Non-equity incentive$0
Pension and deferred compensation$0
All other$433,000
Total$995,179

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ventyx Biosciences, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-057384, and prior-year filings. Open the filing on EDGAR.

Ventyx Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Matthew MooreChief Operating Officer$1,918,110
Raju MohanChief Executive Officer, President and Director$1,283,015
Martin Auster · this pageFormer Chief Financial Officer$995,179
Mark FormanChief Medical Officer$937,465

The full Ventyx Biosciences compensation record

free company brief
Ventyx Biosciences, Inc. (VTYX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Ventyx Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Ventyx Biosciences's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $1,500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ventyx Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy